Jnana Therapeutics
在场
涉及Jnana Therapeutics的并购和融资。
- Otsuka Pharmaceutical has announced the acquisition of Jnana Therapeutics (公布2024八月1号).
高管
查看带有其 21 名主要高管的组织结构图
Jnana Therapeutics 搜索最多的简介
- Joanne Kotz, Director, President and Chief Executive Officer
- Annie Chen, Director
- Matthew Hammond, Director
高管在Jnana Therapeutics变化
- Ron Renaud, Director, 已经离开公司 (新闻发布的2024十月4号).
创建提醒
跟踪 Jnana Therapeutics 的高管变动
生物技术
Jnana Therapeutics 拥有 2,316 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- AgomAb Therapeutics 刚刚宣布为 89 筹款数百万美元。 (公布2024十月29号).
- Seaport Therapeutics 刚刚宣布为 225 筹款数百万美元。 (公布2024十月25号).
- TuHura Biosciences and Kintara Therapeutics have merged (公布2024十月20号)..
生物技术 行业的其他推荐联系人
消息
Jnana Therapeutics 的最新新闻稿
- News & Insights | Jnana Therapeutics
- Jnana Therapeutics to Present Preclinical Data for its PKU Program at the 2022 National PKU Alliance (NPKUA) Conference • Jnana Therapeutics
- Jnana Therapeutics Announces Appointment of Doug Pagán, MBA, as Chief Financial Officer and Chief Operating Officer • Jnana Therapeutics
- Jnana Therapeutics Announces Promotion of Joel Barrish, Ph.D., to President and Chief Scientific Officer • Jnana Therapeutics
- Jnana Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference • Jnana Therapeutics
- Jnana Therapeutics Announces Appointment of John Throup, Ph.D. as Senior Vice President, Head of Development • Jnana Therapeutics
- Jnana Therapeutics to Advance JNT-517 as Development Candidate and Potential First-in-Class Oral Treatment for PKU • Jnana Therapeutics
- Jnana Therapeutics closes $50 million Series B financing to advance lead PKU program and small molecule pipeline based on next gen chemoproteomic platform • Jnana Therapeutics
- Jnana Therapeutics Expands Leadership Team with Two Experienced Biopharmaceutical Executives • Jnana Therapeutics
- Jnana Therapeutics Appoints Dr. Annie Chen to Board of Directors and Dr. Katalin Susztak to Scientific Advisory Board • Jnana Therapeutics
- View more press releases Close
通过电子邮件
